21 Furthermore, the down‐regulation of STAT5 mRNAs and achievement of a major molecular response were observed in CML patients treated with IM and pioglitazone, indicating that targeting STAT5 gene expression might eradicate CML LSCs in vivo.21 Here, STAT5B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.